Citi reiterates Buy rating on Meta Platforms with $800 target
Go back to Citi reiterates Buy rating on Meta Platforms with $800 target| Wendt-Bristol Health Services Corporation (NASDAQ: MDB) | Delayed: 334.68 -75.76 (18.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $410.44 | 52 Week High | $0.00 | |||
| Open | $311.35 | 52 Week Low | $0.00 | |||
| Day High | $344.30 | P/E | N/A | |||
| Day Low | $300.00 | EPS | $0.00 | |||
| Volume | 17,849,428 | |||||
| (NASDAQ: META) | Delayed: 715.62 -36.04 (4.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $751.66 | 52 Week High | $ | |||
| Open | $750.04 | 52 Week Low | $ | |||
| Day High | $750.58 | P/E | N/A | |||
| Day Low | $713.19 | EPS | $ | |||
| Volume | 27,967,444 | |||||
